nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CYP2D6—Lomustine—brain cancer	0.192	0.303	CbGbCtD
Cevimeline—CYP2D6—Hydroxyurea—brain cancer	0.146	0.23	CbGbCtD
Cevimeline—CYP3A4—Temozolomide—brain cancer	0.144	0.227	CbGbCtD
Cevimeline—CYP3A4—Lomustine—brain cancer	0.122	0.193	CbGbCtD
Cevimeline—CYP3A4—Etoposide—brain cancer	0.0295	0.0466	CbGbCtD
Cevimeline—FMO1—Tamoxifen metabolism—CYP2C9—brain cancer	0.00209	0.225	CbGpPWpGaD
Cevimeline—FMO1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000731	0.0787	CbGpPWpGaD
Cevimeline—Chills—Hydroxyurea—brain cancer	0.000586	0.00164	CcSEcCtD
Cevimeline—Tachycardia—Procarbazine—brain cancer	0.000585	0.00164	CcSEcCtD
Cevimeline—Photosensitivity reaction—Temozolomide—brain cancer	0.000581	0.00163	CcSEcCtD
Cevimeline—Weight increased—Temozolomide—brain cancer	0.00058	0.00162	CcSEcCtD
Cevimeline—Hyperhidrosis—Procarbazine—brain cancer	0.000579	0.00162	CcSEcCtD
Cevimeline—Alopecia—Hydroxyurea—brain cancer	0.000577	0.00161	CcSEcCtD
Cevimeline—Weight decreased—Temozolomide—brain cancer	0.000576	0.00161	CcSEcCtD
Cevimeline—Neuropathy peripheral—Carmustine—brain cancer	0.000576	0.00161	CcSEcCtD
Cevimeline—Hyperglycaemia—Temozolomide—brain cancer	0.000575	0.00161	CcSEcCtD
Cevimeline—Stomatitis—Carmustine—brain cancer	0.000573	0.0016	CcSEcCtD
Cevimeline—Urinary tract infection—Carmustine—brain cancer	0.000571	0.0016	CcSEcCtD
Cevimeline—Pneumonia—Temozolomide—brain cancer	0.000571	0.0016	CcSEcCtD
Cevimeline—Anorexia—Procarbazine—brain cancer	0.000571	0.0016	CcSEcCtD
Cevimeline—Depression—Temozolomide—brain cancer	0.000566	0.00159	CcSEcCtD
Cevimeline—Nausea—Lomustine—brain cancer	0.000561	0.00157	CcSEcCtD
Cevimeline—Hypotension—Procarbazine—brain cancer	0.00056	0.00157	CcSEcCtD
Cevimeline—Neuropathy peripheral—Temozolomide—brain cancer	0.000557	0.00156	CcSEcCtD
Cevimeline—Stomatitis—Temozolomide—brain cancer	0.000554	0.00155	CcSEcCtD
Cevimeline—Urinary tract infection—Temozolomide—brain cancer	0.000552	0.00155	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000546	0.00153	CcSEcCtD
Cevimeline—Insomnia—Procarbazine—brain cancer	0.000542	0.00152	CcSEcCtD
Cevimeline—Paraesthesia—Procarbazine—brain cancer	0.000538	0.00151	CcSEcCtD
Cevimeline—Sinusitis—Temozolomide—brain cancer	0.000533	0.00149	CcSEcCtD
Cevimeline—Somnolence—Procarbazine—brain cancer	0.000533	0.00149	CcSEcCtD
Cevimeline—Haemoglobin—Carmustine—brain cancer	0.00053	0.00148	CcSEcCtD
Cevimeline—Haemorrhage—Carmustine—brain cancer	0.000528	0.00148	CcSEcCtD
Cevimeline—Ill-defined disorder—Hydroxyurea—brain cancer	0.000527	0.00148	CcSEcCtD
Cevimeline—Anaemia—Hydroxyurea—brain cancer	0.000525	0.00147	CcSEcCtD
Cevimeline—Hallucination—Carmustine—brain cancer	0.000525	0.00147	CcSEcCtD
Cevimeline—Hypoaesthesia—Carmustine—brain cancer	0.000525	0.00147	CcSEcCtD
Cevimeline—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000521	0.0561	CbGpPWpGaD
Cevimeline—Decreased appetite—Procarbazine—brain cancer	0.000521	0.00146	CcSEcCtD
Cevimeline—Alanine aminotransferase increased—Etoposide—brain cancer	0.00052	0.00146	CcSEcCtD
Cevimeline—Oedema peripheral—Carmustine—brain cancer	0.00052	0.00145	CcSEcCtD
Cevimeline—Fatigue—Procarbazine—brain cancer	0.000517	0.00145	CcSEcCtD
Cevimeline—Haemoglobin—Temozolomide—brain cancer	0.000512	0.00143	CcSEcCtD
Cevimeline—Malaise—Hydroxyurea—brain cancer	0.000512	0.00143	CcSEcCtD
Cevimeline—Pain—Procarbazine—brain cancer	0.000512	0.00143	CcSEcCtD
Cevimeline—Constipation—Procarbazine—brain cancer	0.000512	0.00143	CcSEcCtD
Cevimeline—Haemorrhage—Temozolomide—brain cancer	0.00051	0.00143	CcSEcCtD
Cevimeline—Dysphagia—Etoposide—brain cancer	0.00051	0.00143	CcSEcCtD
Cevimeline—Leukopenia—Hydroxyurea—brain cancer	0.000509	0.00142	CcSEcCtD
Cevimeline—Visual impairment—Carmustine—brain cancer	0.000508	0.00142	CcSEcCtD
Cevimeline—Hallucination—Temozolomide—brain cancer	0.000507	0.00142	CcSEcCtD
Cevimeline—Hypoaesthesia—Temozolomide—brain cancer	0.000507	0.00142	CcSEcCtD
Cevimeline—Pharyngitis—Temozolomide—brain cancer	0.000506	0.00142	CcSEcCtD
Cevimeline—Oedema peripheral—Temozolomide—brain cancer	0.000502	0.00141	CcSEcCtD
Cevimeline—Bronchospasm—Etoposide—brain cancer	0.000501	0.0014	CcSEcCtD
Cevimeline—Urethral disorder—Temozolomide—brain cancer	0.0005	0.0014	CcSEcCtD
Cevimeline—Sweating increased—Etoposide—brain cancer	0.000497	0.00139	CcSEcCtD
Cevimeline—Feeling abnormal—Procarbazine—brain cancer	0.000494	0.00138	CcSEcCtD
Cevimeline—Eye disorder—Carmustine—brain cancer	0.000493	0.00138	CcSEcCtD
Cevimeline—Convulsion—Hydroxyurea—brain cancer	0.000492	0.00138	CcSEcCtD
Cevimeline—Visual impairment—Temozolomide—brain cancer	0.000491	0.00138	CcSEcCtD
Cevimeline—Gastrointestinal pain—Procarbazine—brain cancer	0.00049	0.00137	CcSEcCtD
Cevimeline—Flushing—Carmustine—brain cancer	0.00049	0.00137	CcSEcCtD
Cevimeline—Discomfort—Hydroxyurea—brain cancer	0.000478	0.00134	CcSEcCtD
Cevimeline—Eye disorder—Temozolomide—brain cancer	0.000476	0.00133	CcSEcCtD
Cevimeline—Urticaria—Procarbazine—brain cancer	0.000476	0.00133	CcSEcCtD
Cevimeline—Tinnitus—Temozolomide—brain cancer	0.000475	0.00133	CcSEcCtD
Cevimeline—Abdominal pain—Procarbazine—brain cancer	0.000474	0.00133	CcSEcCtD
Cevimeline—Body temperature increased—Procarbazine—brain cancer	0.000474	0.00133	CcSEcCtD
Cevimeline—Cardiac disorder—Temozolomide—brain cancer	0.000473	0.00132	CcSEcCtD
Cevimeline—Flushing—Temozolomide—brain cancer	0.000473	0.00132	CcSEcCtD
Cevimeline—Arrhythmia—Carmustine—brain cancer	0.000471	0.00132	CcSEcCtD
Cevimeline—Alopecia—Carmustine—brain cancer	0.000466	0.0013	CcSEcCtD
Cevimeline—Oedema—Hydroxyurea—brain cancer	0.000464	0.0013	CcSEcCtD
Cevimeline—Angiopathy—Temozolomide—brain cancer	0.000463	0.00129	CcSEcCtD
Cevimeline—Infection—Hydroxyurea—brain cancer	0.000461	0.00129	CcSEcCtD
Cevimeline—Malnutrition—Carmustine—brain cancer	0.000459	0.00129	CcSEcCtD
Cevimeline—Chills—Temozolomide—brain cancer	0.000457	0.00128	CcSEcCtD
Cevimeline—Pneumonia—Etoposide—brain cancer	0.000457	0.00128	CcSEcCtD
Cevimeline—Nervous system disorder—Hydroxyurea—brain cancer	0.000455	0.00127	CcSEcCtD
Cevimeline—Thrombocytopenia—Hydroxyurea—brain cancer	0.000454	0.00127	CcSEcCtD
Cevimeline—Alopecia—Temozolomide—brain cancer	0.000451	0.00126	CcSEcCtD
Cevimeline—Skin disorder—Hydroxyurea—brain cancer	0.00045	0.00126	CcSEcCtD
Cevimeline—Acute coronary syndrome—Etoposide—brain cancer	0.000448	0.00125	CcSEcCtD
Cevimeline—Neuropathy peripheral—Etoposide—brain cancer	0.000445	0.00125	CcSEcCtD
Cevimeline—Myocardial infarction—Etoposide—brain cancer	0.000445	0.00125	CcSEcCtD
Cevimeline—Back pain—Carmustine—brain cancer	0.000444	0.00124	CcSEcCtD
Cevimeline—Malnutrition—Temozolomide—brain cancer	0.000444	0.00124	CcSEcCtD
Cevimeline—Stomatitis—Etoposide—brain cancer	0.000443	0.00124	CcSEcCtD
Cevimeline—Anorexia—Hydroxyurea—brain cancer	0.000442	0.00124	CcSEcCtD
Cevimeline—Hypersensitivity—Procarbazine—brain cancer	0.000441	0.00124	CcSEcCtD
Cevimeline—Dysgeusia—Temozolomide—brain cancer	0.000435	0.00122	CcSEcCtD
Cevimeline—Tremor—Carmustine—brain cancer	0.00043	0.0012	CcSEcCtD
Cevimeline—Asthenia—Procarbazine—brain cancer	0.00043	0.0012	CcSEcCtD
Cevimeline—Back pain—Temozolomide—brain cancer	0.000429	0.0012	CcSEcCtD
Cevimeline—Anaemia—Carmustine—brain cancer	0.000425	0.00119	CcSEcCtD
Cevimeline—Agranulocytosis—Etoposide—brain cancer	0.000424	0.00119	CcSEcCtD
Cevimeline—Pruritus—Procarbazine—brain cancer	0.000424	0.00119	CcSEcCtD
Cevimeline—Agitation—Carmustine—brain cancer	0.000422	0.00118	CcSEcCtD
Cevimeline—Tremor—Temozolomide—brain cancer	0.000416	0.00116	CcSEcCtD
Cevimeline—Dyspnoea—Hydroxyurea—brain cancer	0.000413	0.00116	CcSEcCtD
Cevimeline—Somnolence—Hydroxyurea—brain cancer	0.000412	0.00115	CcSEcCtD
Cevimeline—Ill-defined disorder—Temozolomide—brain cancer	0.000412	0.00115	CcSEcCtD
Cevimeline—Leukopenia—Carmustine—brain cancer	0.000411	0.00115	CcSEcCtD
Cevimeline—Anaemia—Temozolomide—brain cancer	0.00041	0.00115	CcSEcCtD
Cevimeline—Diarrhoea—Procarbazine—brain cancer	0.00041	0.00115	CcSEcCtD
Cevimeline—Dyspepsia—Hydroxyurea—brain cancer	0.000408	0.00114	CcSEcCtD
Cevimeline—Agitation—Temozolomide—brain cancer	0.000408	0.00114	CcSEcCtD
Cevimeline—Hypoaesthesia—Etoposide—brain cancer	0.000406	0.00114	CcSEcCtD
Cevimeline—Decreased appetite—Hydroxyurea—brain cancer	0.000403	0.00113	CcSEcCtD
Cevimeline—Malaise—Temozolomide—brain cancer	0.0004	0.00112	CcSEcCtD
Cevimeline—Urethral disorder—Etoposide—brain cancer	0.0004	0.00112	CcSEcCtD
Cevimeline—Fatigue—Hydroxyurea—brain cancer	0.0004	0.00112	CcSEcCtD
Cevimeline—Vertigo—Temozolomide—brain cancer	0.000399	0.00112	CcSEcCtD
Cevimeline—Convulsion—Carmustine—brain cancer	0.000398	0.00111	CcSEcCtD
Cevimeline—Leukopenia—Temozolomide—brain cancer	0.000397	0.00111	CcSEcCtD
Cevimeline—Hypertension—Carmustine—brain cancer	0.000397	0.00111	CcSEcCtD
Cevimeline—Constipation—Hydroxyurea—brain cancer	0.000397	0.00111	CcSEcCtD
Cevimeline—Pain—Hydroxyurea—brain cancer	0.000397	0.00111	CcSEcCtD
Cevimeline—Dizziness—Procarbazine—brain cancer	0.000396	0.00111	CcSEcCtD
Cevimeline—Palpitations—Temozolomide—brain cancer	0.000392	0.0011	CcSEcCtD
Cevimeline—Chest pain—Carmustine—brain cancer	0.000391	0.00109	CcSEcCtD
Cevimeline—Myalgia—Carmustine—brain cancer	0.000391	0.00109	CcSEcCtD
Cevimeline—Anxiety—Carmustine—brain cancer	0.00039	0.00109	CcSEcCtD
Cevimeline—FMO1—Biological oxidations—CYP2C9—brain cancer	0.000388	0.0418	CbGpPWpGaD
Cevimeline—Cough—Temozolomide—brain cancer	0.000387	0.00108	CcSEcCtD
Cevimeline—Convulsion—Temozolomide—brain cancer	0.000385	0.00108	CcSEcCtD
Cevimeline—Hypertension—Temozolomide—brain cancer	0.000383	0.00107	CcSEcCtD
Cevimeline—FMO1—Metapathway biotransformation—CYP2C9—brain cancer	0.000383	0.0412	CbGpPWpGaD
Cevimeline—Feeling abnormal—Hydroxyurea—brain cancer	0.000382	0.00107	CcSEcCtD
Cevimeline—Eye disorder—Etoposide—brain cancer	0.000381	0.00107	CcSEcCtD
Cevimeline—Vomiting—Procarbazine—brain cancer	0.000381	0.00107	CcSEcCtD
Cevimeline—Cardiac disorder—Etoposide—brain cancer	0.000379	0.00106	CcSEcCtD
Cevimeline—Flushing—Etoposide—brain cancer	0.000379	0.00106	CcSEcCtD
Cevimeline—Confusional state—Carmustine—brain cancer	0.000378	0.00106	CcSEcCtD
Cevimeline—Arthralgia—Temozolomide—brain cancer	0.000378	0.00106	CcSEcCtD
Cevimeline—Myalgia—Temozolomide—brain cancer	0.000378	0.00106	CcSEcCtD
Cevimeline—Rash—Procarbazine—brain cancer	0.000378	0.00106	CcSEcCtD
Cevimeline—Dermatitis—Procarbazine—brain cancer	0.000377	0.00106	CcSEcCtD
Cevimeline—Anxiety—Temozolomide—brain cancer	0.000377	0.00105	CcSEcCtD
Cevimeline—Headache—Procarbazine—brain cancer	0.000375	0.00105	CcSEcCtD
Cevimeline—Oedema—Carmustine—brain cancer	0.000375	0.00105	CcSEcCtD
Cevimeline—Discomfort—Temozolomide—brain cancer	0.000373	0.00104	CcSEcCtD
Cevimeline—Infection—Carmustine—brain cancer	0.000372	0.00104	CcSEcCtD
Cevimeline—Angiopathy—Etoposide—brain cancer	0.00037	0.00104	CcSEcCtD
Cevimeline—Thrombocytopenia—Carmustine—brain cancer	0.000367	0.00103	CcSEcCtD
Cevimeline—Body temperature increased—Hydroxyurea—brain cancer	0.000367	0.00103	CcSEcCtD
Cevimeline—Chills—Etoposide—brain cancer	0.000366	0.00102	CcSEcCtD
Cevimeline—Tachycardia—Carmustine—brain cancer	0.000366	0.00102	CcSEcCtD
Cevimeline—Confusional state—Temozolomide—brain cancer	0.000365	0.00102	CcSEcCtD
Cevimeline—Oedema—Temozolomide—brain cancer	0.000362	0.00101	CcSEcCtD
Cevimeline—Alopecia—Etoposide—brain cancer	0.000361	0.00101	CcSEcCtD
Cevimeline—Infection—Temozolomide—brain cancer	0.00036	0.00101	CcSEcCtD
Cevimeline—Anorexia—Carmustine—brain cancer	0.000357	0.001	CcSEcCtD
Cevimeline—Nausea—Procarbazine—brain cancer	0.000356	0.000996	CcSEcCtD
Cevimeline—Nervous system disorder—Temozolomide—brain cancer	0.000355	0.000994	CcSEcCtD
Cevimeline—Thrombocytopenia—Temozolomide—brain cancer	0.000355	0.000993	CcSEcCtD
Cevimeline—Skin disorder—Temozolomide—brain cancer	0.000352	0.000985	CcSEcCtD
Cevimeline—Hypotension—Carmustine—brain cancer	0.00035	0.00098	CcSEcCtD
Cevimeline—Hyperhidrosis—Temozolomide—brain cancer	0.00035	0.00098	CcSEcCtD
Cevimeline—Dysgeusia—Etoposide—brain cancer	0.000348	0.000974	CcSEcCtD
Cevimeline—Anorexia—Temozolomide—brain cancer	0.000345	0.000966	CcSEcCtD
Cevimeline—Back pain—Etoposide—brain cancer	0.000344	0.000962	CcSEcCtD
Cevimeline—Hypersensitivity—Hydroxyurea—brain cancer	0.000342	0.000956	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Carmustine—brain cancer	0.000342	0.000956	CcSEcCtD
Cevimeline—Muscle spasms—Etoposide—brain cancer	0.000341	0.000956	CcSEcCtD
Cevimeline—Insomnia—Carmustine—brain cancer	0.000339	0.000949	CcSEcCtD
Cevimeline—Paraesthesia—Carmustine—brain cancer	0.000337	0.000942	CcSEcCtD
Cevimeline—Dyspnoea—Carmustine—brain cancer	0.000334	0.000935	CcSEcCtD
Cevimeline—Somnolence—Carmustine—brain cancer	0.000333	0.000933	CcSEcCtD
Cevimeline—Asthenia—Hydroxyurea—brain cancer	0.000333	0.000931	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00033	0.000924	CcSEcCtD
Cevimeline—Ill-defined disorder—Etoposide—brain cancer	0.00033	0.000922	CcSEcCtD
Cevimeline—Anaemia—Etoposide—brain cancer	0.000328	0.000919	CcSEcCtD
Cevimeline—Insomnia—Temozolomide—brain cancer	0.000328	0.000917	CcSEcCtD
Cevimeline—Decreased appetite—Carmustine—brain cancer	0.000326	0.000912	CcSEcCtD
Cevimeline—Paraesthesia—Temozolomide—brain cancer	0.000325	0.00091	CcSEcCtD
Cevimeline—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000323	0.0348	CbGpPWpGaD
Cevimeline—Dyspnoea—Temozolomide—brain cancer	0.000323	0.000904	CcSEcCtD
Cevimeline—Somnolence—Temozolomide—brain cancer	0.000322	0.000901	CcSEcCtD
Cevimeline—Constipation—Carmustine—brain cancer	0.000321	0.000897	CcSEcCtD
Cevimeline—Pain—Carmustine—brain cancer	0.000321	0.000897	CcSEcCtD
Cevimeline—Malaise—Etoposide—brain cancer	0.00032	0.000896	CcSEcCtD
Cevimeline—Vertigo—Etoposide—brain cancer	0.000319	0.000893	CcSEcCtD
Cevimeline—Dyspepsia—Temozolomide—brain cancer	0.000319	0.000893	CcSEcCtD
Cevimeline—Leukopenia—Etoposide—brain cancer	0.000318	0.00089	CcSEcCtD
Cevimeline—Diarrhoea—Hydroxyurea—brain cancer	0.000317	0.000888	CcSEcCtD
Cevimeline—Decreased appetite—Temozolomide—brain cancer	0.000315	0.000881	CcSEcCtD
Cevimeline—Fatigue—Temozolomide—brain cancer	0.000312	0.000874	CcSEcCtD
Cevimeline—Loss of consciousness—Etoposide—brain cancer	0.000312	0.000874	CcSEcCtD
Cevimeline—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000311	0.0334	CbGpPWpGaD
Cevimeline—Cough—Etoposide—brain cancer	0.00031	0.000867	CcSEcCtD
Cevimeline—Pain—Temozolomide—brain cancer	0.00031	0.000867	CcSEcCtD
Cevimeline—Constipation—Temozolomide—brain cancer	0.00031	0.000867	CcSEcCtD
Cevimeline—Feeling abnormal—Carmustine—brain cancer	0.000309	0.000865	CcSEcCtD
Cevimeline—Convulsion—Etoposide—brain cancer	0.000308	0.000861	CcSEcCtD
Cevimeline—Hypertension—Etoposide—brain cancer	0.000307	0.000858	CcSEcCtD
Cevimeline—Dizziness—Hydroxyurea—brain cancer	0.000307	0.000858	CcSEcCtD
Cevimeline—Gastrointestinal pain—Carmustine—brain cancer	0.000307	0.000858	CcSEcCtD
Cevimeline—Chest pain—Etoposide—brain cancer	0.000302	0.000846	CcSEcCtD
Cevimeline—Discomfort—Etoposide—brain cancer	0.000299	0.000836	CcSEcCtD
Cevimeline—Feeling abnormal—Temozolomide—brain cancer	0.000299	0.000836	CcSEcCtD
Cevimeline—Abdominal pain—Carmustine—brain cancer	0.000296	0.000829	CcSEcCtD
Cevimeline—Body temperature increased—Carmustine—brain cancer	0.000296	0.000829	CcSEcCtD
Cevimeline—Gastrointestinal pain—Temozolomide—brain cancer	0.000296	0.000829	CcSEcCtD
Cevimeline—Vomiting—Hydroxyurea—brain cancer	0.000295	0.000825	CcSEcCtD
Cevimeline—Rash—Hydroxyurea—brain cancer	0.000292	0.000818	CcSEcCtD
Cevimeline—Confusional state—Etoposide—brain cancer	0.000292	0.000818	CcSEcCtD
Cevimeline—Dermatitis—Hydroxyurea—brain cancer	0.000292	0.000818	CcSEcCtD
Cevimeline—Headache—Hydroxyurea—brain cancer	0.00029	0.000813	CcSEcCtD
Cevimeline—Infection—Etoposide—brain cancer	0.000288	0.000806	CcSEcCtD
Cevimeline—Urticaria—Temozolomide—brain cancer	0.000288	0.000805	CcSEcCtD
Cevimeline—Abdominal pain—Temozolomide—brain cancer	0.000286	0.000802	CcSEcCtD
Cevimeline—Body temperature increased—Temozolomide—brain cancer	0.000286	0.000802	CcSEcCtD
Cevimeline—Thrombocytopenia—Etoposide—brain cancer	0.000284	0.000794	CcSEcCtD
Cevimeline—Tachycardia—Etoposide—brain cancer	0.000283	0.000792	CcSEcCtD
Cevimeline—Skin disorder—Etoposide—brain cancer	0.000282	0.000788	CcSEcCtD
Cevimeline—Hyperhidrosis—Etoposide—brain cancer	0.00028	0.000784	CcSEcCtD
Cevimeline—Anorexia—Etoposide—brain cancer	0.000276	0.000773	CcSEcCtD
Cevimeline—Hypersensitivity—Carmustine—brain cancer	0.000276	0.000773	CcSEcCtD
Cevimeline—Nausea—Hydroxyurea—brain cancer	0.000275	0.000771	CcSEcCtD
Cevimeline—Hypotension—Etoposide—brain cancer	0.000271	0.000758	CcSEcCtD
Cevimeline—Asthenia—Carmustine—brain cancer	0.000269	0.000753	CcSEcCtD
Cevimeline—Hypersensitivity—Temozolomide—brain cancer	0.000267	0.000747	CcSEcCtD
Cevimeline—Paraesthesia—Etoposide—brain cancer	0.00026	0.000729	CcSEcCtD
Cevimeline—Asthenia—Temozolomide—brain cancer	0.00026	0.000727	CcSEcCtD
Cevimeline—Dyspnoea—Etoposide—brain cancer	0.000258	0.000723	CcSEcCtD
Cevimeline—Somnolence—Etoposide—brain cancer	0.000258	0.000721	CcSEcCtD
Cevimeline—Diarrhoea—Carmustine—brain cancer	0.000256	0.000718	CcSEcCtD
Cevimeline—Pruritus—Temozolomide—brain cancer	0.000256	0.000717	CcSEcCtD
Cevimeline—Decreased appetite—Etoposide—brain cancer	0.000252	0.000705	CcSEcCtD
Cevimeline—Fatigue—Etoposide—brain cancer	0.00025	0.000699	CcSEcCtD
Cevimeline—Dizziness—Carmustine—brain cancer	0.000248	0.000694	CcSEcCtD
Cevimeline—Constipation—Etoposide—brain cancer	0.000248	0.000694	CcSEcCtD
Cevimeline—Pain—Etoposide—brain cancer	0.000248	0.000694	CcSEcCtD
Cevimeline—Diarrhoea—Temozolomide—brain cancer	0.000248	0.000694	CcSEcCtD
Cevimeline—Dizziness—Temozolomide—brain cancer	0.00024	0.00067	CcSEcCtD
Cevimeline—Feeling abnormal—Etoposide—brain cancer	0.000239	0.000669	CcSEcCtD
Cevimeline—Vomiting—Carmustine—brain cancer	0.000238	0.000667	CcSEcCtD
Cevimeline—Gastrointestinal pain—Etoposide—brain cancer	0.000237	0.000663	CcSEcCtD
Cevimeline—Rash—Carmustine—brain cancer	0.000236	0.000662	CcSEcCtD
Cevimeline—Dermatitis—Carmustine—brain cancer	0.000236	0.000661	CcSEcCtD
Cevimeline—Headache—Carmustine—brain cancer	0.000235	0.000657	CcSEcCtD
Cevimeline—Vomiting—Temozolomide—brain cancer	0.00023	0.000645	CcSEcCtD
Cevimeline—Urticaria—Etoposide—brain cancer	0.00023	0.000645	CcSEcCtD
Cevimeline—Abdominal pain—Etoposide—brain cancer	0.000229	0.000641	CcSEcCtD
Cevimeline—Body temperature increased—Etoposide—brain cancer	0.000229	0.000641	CcSEcCtD
Cevimeline—Rash—Temozolomide—brain cancer	0.000228	0.000639	CcSEcCtD
Cevimeline—Dermatitis—Temozolomide—brain cancer	0.000228	0.000639	CcSEcCtD
Cevimeline—Headache—Temozolomide—brain cancer	0.000227	0.000635	CcSEcCtD
Cevimeline—Nausea—Carmustine—brain cancer	0.000223	0.000623	CcSEcCtD
Cevimeline—Nausea—Temozolomide—brain cancer	0.000215	0.000602	CcSEcCtD
Cevimeline—Hypersensitivity—Etoposide—brain cancer	0.000214	0.000598	CcSEcCtD
Cevimeline—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000211	0.0227	CbGpPWpGaD
Cevimeline—Asthenia—Etoposide—brain cancer	0.000208	0.000582	CcSEcCtD
Cevimeline—Pruritus—Etoposide—brain cancer	0.000205	0.000574	CcSEcCtD
Cevimeline—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000203	0.0219	CbGpPWpGaD
Cevimeline—Diarrhoea—Etoposide—brain cancer	0.000198	0.000555	CcSEcCtD
Cevimeline—Dizziness—Etoposide—brain cancer	0.000192	0.000537	CcSEcCtD
Cevimeline—Vomiting—Etoposide—brain cancer	0.000184	0.000516	CcSEcCtD
Cevimeline—Rash—Etoposide—brain cancer	0.000183	0.000512	CcSEcCtD
Cevimeline—Dermatitis—Etoposide—brain cancer	0.000183	0.000511	CcSEcCtD
Cevimeline—Headache—Etoposide—brain cancer	0.000182	0.000508	CcSEcCtD
Cevimeline—Nausea—Etoposide—brain cancer	0.000172	0.000482	CcSEcCtD
Cevimeline—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000145	0.0156	CbGpPWpGaD
Cevimeline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000138	0.0149	CbGpPWpGaD
Cevimeline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000134	0.0144	CbGpPWpGaD
Cevimeline—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000132	0.0142	CbGpPWpGaD
Cevimeline—CHRM1—Regulation of Actin Cytoskeleton—PPP1R12A—brain cancer	0.000131	0.0141	CbGpPWpGaD
Cevimeline—CHRM3—Regulation of Actin Cytoskeleton—PPP1R12A—brain cancer	0.000131	0.0141	CbGpPWpGaD
Cevimeline—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000109	0.0117	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—NTRK3—brain cancer	9.6e-05	0.0103	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Other—SMO—brain cancer	8.81e-05	0.00948	CbGpPWpGaD
Cevimeline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	8.77e-05	0.00944	CbGpPWpGaD
Cevimeline—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	8.66e-05	0.00931	CbGpPWpGaD
Cevimeline—CYP3A4—Irinotecan Pathway—APC—brain cancer	7.45e-05	0.00801	CbGpPWpGaD
Cevimeline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	7.11e-05	0.00765	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—CYP2C9—brain cancer	6.64e-05	0.00715	CbGpPWpGaD
Cevimeline—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	6.61e-05	0.00711	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—CYP2C9—brain cancer	5.78e-05	0.00621	CbGpPWpGaD
Cevimeline—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	5.7e-05	0.00613	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—BSG—brain cancer	5.65e-05	0.00608	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—PTCH2—brain cancer	5.13e-05	0.00552	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—PTCH2—brain cancer	5.11e-05	0.0055	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—TRPC6—brain cancer	5.05e-05	0.00544	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—TRPC6—brain cancer	5.04e-05	0.00542	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—IDH1—brain cancer	4.86e-05	0.00522	CbGpPWpGaD
Cevimeline—CHRM1—Regulation of Actin Cytoskeleton—VAV1—brain cancer	4.54e-05	0.00488	CbGpPWpGaD
Cevimeline—CHRM3—Regulation of Actin Cytoskeleton—VAV1—brain cancer	4.53e-05	0.00487	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	4.52e-05	0.00486	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	4.5e-05	0.00485	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—OR4C12—brain cancer	4.5e-05	0.00484	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—OR14C36—brain cancer	4.5e-05	0.00484	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—OR4C12—brain cancer	4.48e-05	0.00482	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—OR14C36—brain cancer	4.48e-05	0.00482	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—OR4C12—brain cancer	4.09e-05	0.00439	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—OR14C36—brain cancer	4.09e-05	0.00439	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—OR14C36—brain cancer	4.07e-05	0.00438	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—OR4C12—brain cancer	4.07e-05	0.00438	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—ENO2—brain cancer	3.84e-05	0.00413	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—CYP2C9—brain cancer	3.78e-05	0.00406	CbGpPWpGaD
Cevimeline—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	3.73e-05	0.00401	CbGpPWpGaD
Cevimeline—CHRM1—Regulation of Actin Cytoskeleton—PDGFRA—brain cancer	3.72e-05	0.004	CbGpPWpGaD
Cevimeline—CHRM3—Regulation of Actin Cytoskeleton—PDGFRA—brain cancer	3.71e-05	0.00399	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—SIRT1—brain cancer	3.19e-05	0.00343	CbGpPWpGaD
Cevimeline—CHRM1—Regulation of Actin Cytoskeleton—APC—brain cancer	2.88e-05	0.0031	CbGpPWpGaD
Cevimeline—CHRM1—Regulation of Actin Cytoskeleton—PIK3CG—brain cancer	2.88e-05	0.0031	CbGpPWpGaD
Cevimeline—CHRM3—Regulation of Actin Cytoskeleton—APC—brain cancer	2.87e-05	0.00309	CbGpPWpGaD
Cevimeline—CHRM3—Regulation of Actin Cytoskeleton—PIK3CG—brain cancer	2.87e-05	0.00309	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—SHH—brain cancer	2.64e-05	0.00284	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—SHH—brain cancer	2.63e-05	0.00283	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PTCH2—brain cancer	2.63e-05	0.00283	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PTCH2—brain cancer	2.62e-05	0.00282	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—SMO—brain cancer	2.51e-05	0.00269	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—PTCH1—brain cancer	2.51e-05	0.00269	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—PTCH1—brain cancer	2.5e-05	0.00269	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—SMO—brain cancer	2.5e-05	0.00269	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—OR4C12—brain cancer	2.41e-05	0.0026	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—OR14C36—brain cancer	2.41e-05	0.0026	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—CDK4—brain cancer	2.41e-05	0.00259	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—OR4C12—brain cancer	2.41e-05	0.00259	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—OR14C36—brain cancer	2.41e-05	0.00259	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—ABR—brain cancer	2.27e-05	0.00245	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—ABR—brain cancer	2.27e-05	0.00244	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—ABR—brain cancer	2.07e-05	0.00222	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—ABR—brain cancer	2.06e-05	0.00222	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—DTX2—brain cancer	2.05e-05	0.00221	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—DTX2—brain cancer	2.05e-05	0.0022	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—PIK3CG—brain cancer	1.76e-05	0.00189	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CYP2C9—brain cancer	1.65e-05	0.00178	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PTCH2—brain cancer	1.56e-05	0.00167	CbGpPWpGaD
Cevimeline—CHRM1—Regulation of Actin Cytoskeleton—EGFR—brain cancer	1.55e-05	0.00167	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PTCH2—brain cancer	1.55e-05	0.00167	CbGpPWpGaD
Cevimeline—CHRM3—Regulation of Actin Cytoskeleton—EGFR—brain cancer	1.55e-05	0.00166	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HES5—brain cancer	1.51e-05	0.00162	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HES5—brain cancer	1.5e-05	0.00162	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—STRADA—brain cancer	1.46e-05	0.00157	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—STRADA—brain cancer	1.46e-05	0.00157	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—TRPC6—brain cancer	1.44e-05	0.00155	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—TRPC6—brain cancer	1.44e-05	0.00154	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—BSG—brain cancer	1.41e-05	0.00151	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—SHH—brain cancer	1.36e-05	0.00146	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—SHH—brain cancer	1.35e-05	0.00145	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—TRPC6—brain cancer	1.31e-05	0.00141	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—TRPC6—brain cancer	1.3e-05	0.0014	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—SMO—brain cancer	1.29e-05	0.00138	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PTCH1—brain cancer	1.29e-05	0.00138	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—SMO—brain cancer	1.28e-05	0.00138	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PTCH1—brain cancer	1.28e-05	0.00138	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ABR—brain cancer	1.22e-05	0.00131	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ABR—brain cancer	1.22e-05	0.00131	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—IDH1—brain cancer	1.21e-05	0.0013	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GLI2—brain cancer	1.18e-05	0.00127	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GLI2—brain cancer	1.17e-05	0.00126	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	1.16e-05	0.00124	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	1.15e-05	0.00124	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GLI1—brain cancer	1.11e-05	0.00119	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GLI1—brain cancer	1.1e-05	0.00119	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—VAV1—brain cancer	1.08e-05	0.00116	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—VAV1—brain cancer	1.08e-05	0.00116	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SUFU—brain cancer	1.05e-05	0.00113	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SUFU—brain cancer	1.05e-05	0.00113	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—TP53—brain cancer	1.03e-05	0.0011	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GFAP—brain cancer	1.01e-05	0.00109	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GFAP—brain cancer	1.01e-05	0.00109	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP2C9—brain cancer	9.88e-06	0.00106	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—VAV1—brain cancer	9.8e-06	0.00105	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—VAV1—brain cancer	9.77e-06	0.00105	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HEY1—brain cancer	9.61e-06	0.00103	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HEY1—brain cancer	9.58e-06	0.00103	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ENO2—brain cancer	9.55e-06	0.00103	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—DLL1—brain cancer	9.42e-06	0.00101	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—DLL1—brain cancer	9.39e-06	0.00101	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—BSG—brain cancer	8.4e-06	0.000904	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SHH—brain cancer	8.01e-06	0.000862	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SHH—brain cancer	7.99e-06	0.000859	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TRPC6—brain cancer	7.73e-06	0.000831	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TRPC6—brain cancer	7.7e-06	0.000828	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SMO—brain cancer	7.59e-06	0.000817	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PTCH1—brain cancer	7.59e-06	0.000817	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SMO—brain cancer	7.57e-06	0.000814	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PTCH1—brain cancer	7.57e-06	0.000814	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—IDH1—brain cancer	7.22e-06	0.000777	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PIK3CG—brain cancer	6.85e-06	0.000737	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PIK3CG—brain cancer	6.83e-06	0.000735	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP2C9—brain cancer	6.46e-06	0.000695	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PIK3CG—brain cancer	6.22e-06	0.000669	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PIK3CG—brain cancer	6.2e-06	0.000667	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NOTCH2—brain cancer	6.07e-06	0.000653	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NOTCH2—brain cancer	6.05e-06	0.000651	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—VAV1—brain cancer	5.79e-06	0.000623	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—VAV1—brain cancer	5.77e-06	0.000621	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ENO2—brain cancer	5.71e-06	0.000614	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—BSG—brain cancer	5.49e-06	0.000591	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HES1—brain cancer	4.98e-06	0.000536	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HES1—brain cancer	4.96e-06	0.000534	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—IL2—brain cancer	4.82e-06	0.000519	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—IL2—brain cancer	4.81e-06	0.000517	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PDGFRA—brain cancer	4.74e-06	0.00051	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PDGFRA—brain cancer	4.72e-06	0.000508	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—IDH1—brain cancer	4.72e-06	0.000508	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SPP1—brain cancer	4.6e-06	0.000495	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SPP1—brain cancer	4.59e-06	0.000493	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PIK3CG—brain cancer	4.38e-06	0.000471	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL2—brain cancer	4.38e-06	0.000471	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL2—brain cancer	4.36e-06	0.000469	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IRS2—brain cancer	4.16e-06	0.000448	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IRS2—brain cancer	4.15e-06	0.000446	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ENO2—brain cancer	3.73e-06	0.000402	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APC—brain cancer	3.68e-06	0.000395	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PIK3CG—brain cancer	3.68e-06	0.000395	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APC—brain cancer	3.66e-06	0.000394	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PIK3CG—brain cancer	3.66e-06	0.000394	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—EGFR—brain cancer	3.35e-06	0.00036	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—EGFR—brain cancer	3.34e-06	0.000359	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RELA—brain cancer	2.87e-06	0.000309	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RELA—brain cancer	2.86e-06	0.000308	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ERBB2—brain cancer	2.85e-06	0.000307	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ERBB2—brain cancer	2.84e-06	0.000306	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3CG—brain cancer	2.62e-06	0.000282	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL2—brain cancer	2.59e-06	0.000278	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL2—brain cancer	2.58e-06	0.000277	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCND1—brain cancer	2.52e-06	0.000271	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCND1—brain cancer	2.51e-06	0.00027	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CTNNB1—brain cancer	2.5e-06	0.000269	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CTNNB1—brain cancer	2.49e-06	0.000268	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—VEGFA—brain cancer	2.2e-06	0.000236	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—VEGFA—brain cancer	2.19e-06	0.000236	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—STAT3—brain cancer	2.18e-06	0.000234	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—STAT3—brain cancer	2.17e-06	0.000233	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MYC—brain cancer	2.02e-06	0.000218	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MYC—brain cancer	2.02e-06	0.000217	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EGFR—brain cancer	1.98e-06	0.000213	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EGFR—brain cancer	1.97e-06	0.000212	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3CG—brain cancer	1.71e-06	0.000184	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TP53—brain cancer	1.66e-06	0.000179	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TP53—brain cancer	1.66e-06	0.000178	CbGpPWpGaD
